Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)(A), Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)(B), Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)(C), Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)(D), Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)(E), Österreichische Gesellschaft für Pneumologie (ÖGP)(F) in co-operation with the German, Austrian, and Swiss ARIA groups(G), and the European Academy of Allergy and Clinical Immunology (EAACI)(H).
- DOI
- 10.5414/alx02166e
- Published
- 2020
- Container
- Allergologie select
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.5414/alx02166e,
title = {Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)(A), Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)(B), Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)(C), Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)(D), Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)(E), Österreichische Gesellschaft für Pneumologie (ÖGP)(F) in co-operation with the German, Austrian, and Swiss ARIA groups(G), and the European Academy of Allergy and Clinical Immunology (EAACI)(H).},
author = {Klimek L and Pfaar O and Worm M and Eiwegger T and Hagemann J and Ollert M and Untersmayr E and Hoffmann-Sommergruber K and Vultaggio A and Agache I and Bavbek S and Bossios A and Casper I and Chan S and Chatzipetrou A and Vogelberg C and Firinu D and Kauppi P and Kolios A and Kothari A and Matucci A and Palomares O and Szépfalusi Z and Pohl W and Hötzenecker W and Rosenkranz AR and Bergmann KC and Bieber T and Buhl R and Buters J and Darsow U and Keil T and Kleine-Tebbe J and Lau S and Maurer M and Merk H and Mösges R and Saloga J and Staubach P and Jappe U and Rabe KF and Rabe U and Vogelmeier C and Biedermann T and Jung K and Schlenter W and Ring J and Chaker A and Wehrmann W and Becker S and Freudelsperger L and Mülleneisen N and Nemat K and Czech W and Wrede H and Brehler R and Fuchs T and Tomazic PV and Aberer W and Fink-Wagner AH and Horak F and Wöhrl S and Niederberger-Leppin V and Pali-Schöll I and Pohl W and Roller-Wirnsberger R and Spranger O and Valenta R and Akdis M and Matricardi PM and Spertini F and Khaltaev N and Michel JP and Nicod L and Schmid-Grendelmeier P and Idzko M and Hamelmann E and Jakob T and Werfel T and Wagenmann M and Taube C and Jensen-Jarolim E and Korn S and Hentges F and Schwarze J and O Mahony L and Knol EF and Del Giacco S and Chivato Pérez T and Bousquet J and Bedbrook A and Zuberbier T and Akdis C and Jutel M},
year = {2020},
journal = {Allergologie select},
doi = {10.5414/alx02166e},
url = {https://doi.org/10.5414/alx02166e}
}RIS
TY - JOUR TI - Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)(A), Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)(B), Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)(C), Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)(D), Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)(E), Österreichische Gesellschaft für Pneumologie (ÖGP)(F) in co-operation with the German, Austrian, and Swiss ARIA groups(G), and the European Academy of Allergy and Clinical Immunology (EAACI)(H). AU - Klimek L AU - Pfaar O AU - Worm M AU - Eiwegger T AU - Hagemann J AU - Ollert M AU - Untersmayr E AU - Hoffmann-Sommergruber K AU - Vultaggio A AU - Agache I AU - Bavbek S AU - Bossios A AU - Casper I AU - Chan S AU - Chatzipetrou A AU - Vogelberg C AU - Firinu D AU - Kauppi P AU - Kolios A AU - Kothari A AU - Matucci A AU - Palomares O AU - Szépfalusi Z AU - Pohl W AU - Hötzenecker W AU - Rosenkranz AR AU - Bergmann KC AU - Bieber T AU - Buhl R AU - Buters J AU - Darsow U AU - Keil T AU - Kleine-Tebbe J AU - Lau S AU - Maurer M AU - Merk H AU - Mösges R AU - Saloga J AU - Staubach P AU - Jappe U AU - Rabe KF AU - Rabe U AU - Vogelmeier C AU - Biedermann T AU - Jung K AU - Schlenter W AU - Ring J AU - Chaker A AU - Wehrmann W AU - Becker S AU - Freudelsperger L AU - Mülleneisen N AU - Nemat K AU - Czech W AU - Wrede H AU - Brehler R AU - Fuchs T AU - Tomazic PV AU - Aberer W AU - Fink-Wagner AH AU - Horak F AU - Wöhrl S AU - Niederberger-Leppin V AU - Pali-Schöll I AU - Pohl W AU - Roller-Wirnsberger R AU - Spranger O AU - Valenta R AU - Akdis M AU - Matricardi PM AU - Spertini F AU - Khaltaev N AU - Michel JP AU - Nicod L AU - Schmid-Grendelmeier P AU - Idzko M AU - Hamelmann E AU - Jakob T AU - Werfel T AU - Wagenmann M AU - Taube C AU - Jensen-Jarolim E AU - Korn S AU - Hentges F AU - Schwarze J AU - O Mahony L AU - Knol EF AU - Del Giacco S AU - Chivato Pérez T AU - Bousquet J AU - Bedbrook A AU - Zuberbier T AU - Akdis C AU - Jutel M PY - 2020 JO - Allergologie select DO - 10.5414/alx02166e UR - https://doi.org/10.5414/alx02166e ER -
APA
L, K., O, P., M, W., T, E., J, H., M, O., E, U., K, H., A, V., I, A., S, B., A, B., I, C., S, C., A, C., C, V., D, F., P, K., A, K., A, K., A, M., O, P., Z, S., W, P., W, H., AR, R., KC, B., T, B., R, B., J, B., U, D., T, K., J, K., S, L., M, M., H, M., R, M., J, S., P, S., U, J., KF, R., U, R., C, V., T, B., K, J., W, S., J, R., A, C., W, W., S, B., L, F., N, M., K, N., W, C., H, W., R, B., T, F., PV, T., W, A., AH, F., F, H., S, W., V, N., I, P., W, P., R, R., O, S., R, V., M, A., PM, M., F, S., N, K., JP, M., L, N., P, S., M, I., E, H., T, J., T, W., M, W., C, T., E, J., S, K., F, H., J, S., L, O. M., EF, K., S, D. G., T, C. P., J, B., A, B., T, Z., C, A., & M, J. (2020). Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)(A), Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)(B), Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)(C), Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)(D), Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)(E), Österreichische Gesellschaft für Pneumologie (ÖGP)(F) in co-operation with the German, Austrian, and Swiss ARIA groups(G), and the European Academy of Allergy and Clinical Immunology (EAACI)(H).. Allergologie select. https://doi.org/10.5414/alx02166e
Source records
- pubmed · retrieved 2026-09-26T09:32:43.791Z